Hjerpe A - Search Results

1

Laboratory audit as part of the quality assessment of a primary HPV-screening program.

Hortlund M, Sundström K, Lamin H, Hjerpe A, Dillner J. Hortlund M, et al. Among authors: hjerpe a. J Clin Virol. 2016 Feb;75:33-6. doi: 10.1016/j.jcv.2015.12.007. Epub 2015 Dec 24. J Clin Virol. 2016. PMID: 26748032

2

Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study.

Norman I, Hjerpe A, Dillner J. Norman I, et al. Among authors: hjerpe a. BMJ Open. 2017 Dec 14;7(12):e017070. doi: 10.1136/bmjopen-2017-017070. BMJ Open. 2017. PMID: 29247086 Free PMC article.

3

Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program.

Hortlund M, Mühr LSA, Lagheden C, Hjerpe A, Dillner J. Hortlund M, et al. Among authors: hjerpe a. Int J Cancer. 2021 Dec 15;149(12):2083-2090. doi: 10.1002/ijc.33769. Epub 2021 Aug 31. Int J Cancer. 2021. PMID: 34418082

4

Atypical glandular cells and development of cervical cancer: Population-based cohort study.

Norman I, Yilmaz E, Hjerpe A, Hortlund M, Elfström KM, Dillner J. Norman I, et al. Among authors: hjerpe a. Int J Cancer. 2022 Dec 1;151(11):2012-2019. doi: 10.1002/ijc.34242. Epub 2022 Aug 27. Int J Cancer. 2022. PMID: 36029205 Free PMC article.

5

A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears.

Chua KL, Wiklund F, Lenner P, Angström T, Hallmans G, Bergman F, Sapp M, Schiller J, Wadell G, Hjerpe A, Dillner J. Chua KL, et al. Among authors: hjerpe a. Int J Cancer. 1996 Sep 27;68(1):54-9. doi: 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8895541

6

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.

Scott DR, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, Sherman ME, Stoler MH, Kurman RJ, Kiviat NB, Manos MM, Schiffman M. Scott DR, et al. Among authors: hjerpe a. Cancer. 2002 Feb 25;96(1):14-20. doi: 10.1002/cncr.10317. Cancer. 2002. PMID: 11836698 Free article.

7

Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screening.

Fröberg M, Norman I, Johansson B, Hjerpe A, Weiderpass E, Andersson S. Fröberg M, et al. Among authors: hjerpe a. Curr Pharm Des. 2013;19(8):1406-11. Curr Pharm Des. 2013. PMID: 23016773

8

Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K. Andersson S, et al. Among authors: hjerpe a. Am J Pathol. 2009 Nov;175(5):1831-47. doi: 10.2353/ajpath.2009.090122. Am J Pathol. 2009. PMID: 19880826 Free PMC article.

9

High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.

Norman I, Hjerpe A, Andersson S. Norman I, et al. Among authors: hjerpe a. Oncol Rep. 2013 Aug;30(2):695-700. doi: 10.3892/or.2013.2538. Epub 2013 Jun 11. Oncol Rep. 2013. PMID: 23756570

10

Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities.

Fröberg M, Johansson B, Hjerpe A, Andersson S. Fröberg M, et al. Among authors: hjerpe a. Br J Cancer. 2008 Aug 19;99(4):563-8. doi: 10.1038/sj.bjc.6604504. Br J Cancer. 2008. PMID: 18682715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters